Join the club for FREE to access the whole archive and other member benefits.

Marco Quarta

Co-Founder CEO at Rubedo Life Sciences.

Following a Masters degree in Biotechnology, a PhD in Neuroscience, and post-doctoral training in Stem Cells and Regenerative Medicine, he then led a team at Stanford University focused on translational medical research in the Department of Neurology and Neurological Sciences. Previously, he did a post doc at Stanford with his mentor, Prof. Thomas Rando, a world leader in the field of Stem Cells and Aging Studies. Marco Quarta is authors of several scientific publications in top tier journals (such as Nature, Nature Biotechnology, Cell Stem Cell, Nature Communications), and he is an inventor on U.S. patents.

Visit website:


See also: Company Rubedo Life Sciences - Extending Health Span and Reverting Age-Related Diseases.

Marco Quarta is also referenced in the following:

ARDD 2022 - 9th Aging Research and Drug Discovery Meeting

29-Aug-2022 to 02-Sep-2022

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

CULS Webinar: Marco Quarta


Online webinar by Cambridge University Longevity Society with Marco Quarta, Co-Founder & CEO of Rubedo Life Sciences as speaker

Marco Quarta Blog Posts

Highlights of Ending Age-Related Diseases 2020

Highlights of Ending Age-Related Diseases 2020

Key points from 20 presentations from world-leading researchers

Marco Quarta News

Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year


Rubedo to first work on lung diseases

Longevity Technology - 20-Jan-2021

Their work will be critical amidst the COVID-19 pandemic - to move into clinical trials soon